Neurodevelopmental origin of cognitive impairment in schizophrenia

被引:101
|
作者
Bora, E. [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic 3010, Australia
[2] Melbourne Hlth, Melbourne, Vic, Australia
关键词
Cognition; cognitive reserve; neurodevelopment; psychosis; schizophrenia; METABOLIC SYNDROME; NEGATIVE SYMPTOMS; 1ST-EPISODE SCHIZOPHRENIA; EXECUTIVE FUNCTIONS; POSTONSET PERIOD; OLDER-ADULTS; DEFICITS; CHILDHOOD; PSYCHOSIS; RESERVE;
D O I
10.1017/S0033291714001263
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Cognitive impairment is a common feature of schizophrenia; however, its origin remains controversial. Neurodevelopmental abnormalities clearly play a role in pre-morbid cognitive dysfunction in schizophrenia, yet many authors believe that schizophrenia is characterized by illness-related cognitive decline before and after onset of the psychosis that can be the result of neurodegenerative changes. The main reasons behinds such arguments include, first, the evidence showing that effect sizes of the cognitive deficits in subjects who develop adult schizophrenia gradually increase in the first two decades of life and, second, the fact that there is functional decline in many patients with schizophrenia over the years. In this Editorial, I argue that current evidence suggests that illness-related cognitive impairment is neurodevelopmental in origin and characterized by slower gain (developmental lag) but not cognitive decline continuing throughout the first two decades of life. I introduce a model suggesting that neurodevelopmental abnormality can in fact explain the course of cognitive dysfunction and variations in the trajectory of functional decline throughout the life in individuals with schizophrenia. In this model, the severity of underlying neurodevelopmental abnormality determines the age that cognitive deficits first become apparent and contributes to the cognitive reserve of the individual. Interaction of neurodevelopmental abnormality with clinical symptoms, especially negative symptoms and aging, vascular changes, psychological and iatrogenic factors contributes to the heterogeneity of the functional trajectory observed in this disorder.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
    Cotter, Jack
    Barnett, Jennifer H.
    Granger, Kiri
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [2] SIMILARITIES IN COGNITIVE IMPAIRMENT BETWEEN RECENT-ONSET AND CHRONIC SCHIZOPHRENIA PATIENTS: A CONSIDERATION FOR THE NEURODEVELOPMENTAL HYPOTHESIS
    Mondragon-Maya, Alejandra
    Flores-Medina, Yvonne
    Gonzalez-Sanchez, Daniel
    Hernandez-Echeagaray, Elizabeth
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2023, 51 (04): : 176 - 183
  • [3] The age of onset and cognitive impairment at the early stage of schizophrenia
    Yin, Yi
    Li, Shuangshuang
    Tong, Jinghui
    Huang, Junchao
    Tian, Baopeng
    Chen, Song
    Cui, Yimin
    Tan, Shuping
    Wang, Zhiren
    Yang, Fude
    Tong, Yongsheng
    Hong, L. Elliot
    Tan, Yunlong
    COGNITIVE NEURODYNAMICS, 2023, 17 (01) : 183 - 190
  • [4] Developmental trajectory of cognitive impairment in bipolar disorder: Comparison with schizophrenia
    Bora, Emre
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (02) : 158 - 168
  • [5] Cognitive impairment in schizophrenia: the great unmet need
    Aquila, Ralph
    Citrome, Leslie
    CNS SPECTRUMS, 2015, 20 : 35 - 39
  • [6] The Role of Low Cognitive Effort and Negative Symptoms in Neuropsychological Impairment in Schizophrenia
    Strauss, Gregory P.
    Morra, Lindsay F.
    Sullivan, Sara K.
    Gold, James M.
    NEUROPSYCHOLOGY, 2015, 29 (02) : 282 - 291
  • [7] The treatment of cognitive impairment in schizophrenia
    Goff, Donald C.
    Hill, Michele
    Barch, Deanna
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (02) : 245 - 253
  • [8] Cognitive impairment in schizophrenia across age groups: a case-control study
    Mosiolek, Anna
    Gierus, Jacek
    Koweszko, Tytus
    Szulc, Agata
    BMC PSYCHIATRY, 2016, 16
  • [9] Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis
    Bora, Emre
    PSYCHOLOGICAL MEDICINE, 2019, 49 (12) : 1971 - 1979
  • [10] Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia
    Vita, Antonio
    Nibbio, Gabriele
    Barlati, Stefano
    PSYCHIATRY RESEARCH, 2024, 340